254 related articles for article (PubMed ID: 15498777)
1. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
[TBL] [Abstract][Full Text] [Related]
3. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD; Lee HL; Peng CW
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
[TBL] [Abstract][Full Text] [Related]
4. Replication licensing of the EBV oriP minichromosome.
Hirai K; Shirakata M
Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
[TBL] [Abstract][Full Text] [Related]
6. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
[TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
Deakyne JS; Malecka KA; Messick TE; Lieberman PM
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
[TBL] [Abstract][Full Text] [Related]
8. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
9. Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.
Hsieh DJ; Camiolo SM; Yates JL
EMBO J; 1993 Dec; 12(13):4933-44. PubMed ID: 8262037
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
[TBL] [Abstract][Full Text] [Related]
11. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
[TBL] [Abstract][Full Text] [Related]
12. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
Boreström C; Forsman A; Rüetschi U; Rymo L
J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
[TBL] [Abstract][Full Text] [Related]
13. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.
Schepers A; Ritzi M; Bousset K; Kremmer E; Yates JL; Harwood J; Diffley JF; Hammerschmidt W
EMBO J; 2001 Aug; 20(16):4588-602. PubMed ID: 11500385
[TBL] [Abstract][Full Text] [Related]
14. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
[TBL] [Abstract][Full Text] [Related]
15. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
16. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
17. Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.
Zhu J; Liao G; Shan L; Zhang J; Chen MR; Hayward GS; Hayward SD; Desai P; Zhu H
J Virol; 2009 May; 83(10):5219-31. PubMed ID: 19244323
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
19. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
20. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes.
Dresang LR; Vereide DT; Sugden B
J Virol; 2009 Apr; 83(7):2930-40. PubMed ID: 19129441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
